felix-lipov-shutterstock-com
Felix Lipov / Shutterstock.com
6 May 2016Americas

FTC settles Hikma Roxane competition concerns

The US Federal Trade Commission (FTC) has approved a final order settling charges that pharmaceutical company Hikma’s buyout of Roxane Laboratories and Boehringer Ingelheim Roxane would be anticompetitive.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
5 May 2016   AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.

More on this story

Americas
5 May 2016   AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.

More on this story

Americas
5 May 2016   AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.